BIOLAB

Based in China, BIOLAB is a technology company focused on scientifically-backed skincare solutions designed to address various skin concerns through advanced technology and clinical practice. Founded in 2019, BIOLAB operates from Shanghai, China, specializing in the development of innovative skincare products. The company was established by Shuqi Han and currently has Bunjamin Alili as CEO. Since its inception, BIOLAB has engaged in one funding deal, with the most recent funding occurring on March 17, 2021.

BIOLAB听研 specializes in a scientifically-backed skincare line that employs advanced technology and clinical practice. Its core offerings target various skin concerns through rigorous scientific research, appealing to consumers seeking effective and clinically validated skincare remedies. The products are marketed in China and key international markets, catering to wellness-focused individuals. BIOLAB听研's revenue model is based on direct-to-consumer sales through online platforms, including their Tmall flagship store, ensuring a streamlined purchasing experience.

Although specific pricing details are not disclosed, the product range consists of unique formulations that leverage technology, aimed at a diverse customer base, facilitating broader distribution through potential retail partnerships. Following the Series Pre-A funding raised in March 2021, BIOLAB plans to enhance its product lineup with new skincare solutions targeting emerging consumer needs. The company is also looking to expand into additional international markets, with a focus on key regions in Asia and Europe by late 2023. The recent funding will be utilized to support these product development initiatives and market expansion efforts.